Match Document Document Title
7264923 Norovirus infected cell cultures and uses therefor  
A norovirus-permissive cell culture infected with a norovirus, and methods of culturing a norovirus, are disclosed. Norovirus-permissive cells include dendritic cell-lineage cells, and...
RE39815 Method for determining ion channel activity of a substance  
A method for determining the ion channel activity of a substance comprises the steps of (i) expressing the substance as a heterologous protein in a host cell, and (ii) determining changes in...
7262051 Use of biscistronic DNA constructs for identifying compounds that inhibit IRES-dependent translation  
The present invention relates to use of bicistronic DNA constructs for identifying compounds that inhibits IRES-dependent translation activity of an infectious enterovirus (EV) or...
7255864 Diagnostic reagent for hepatitis C virus infection  
A diagnostic reagent for hepatitis C virus infection obtained by sensitizing a solid phase with HCV antigen and a conjugated antigen prepared by chemical bonding of HCV antigen and a carrier...
7255986 Compositions for the diagnosis and treatment of epizootic catarrhal enteritis in ferrets  
The present invention relates to the use of novel nucleotide sequences for the M and N region peptide of the ferret coronavirus and derivative products for the diagnosis and treatment of epizootic...
7255992 Methods for rapid detection and identification of bioagents for environmental and product testing  
The present invention provides methods for rapid detection of bioagents for environmental and product testing. The methods can be used for testing air, water, soil, surfaces of buildings,...
7253277 Nanoparticle polyanion conjugates and methods of use thereof in detecting analytes  
This invention provides polyanionic polymer conjugates containing non-nucleotide polyanionic polymers that are useful in detecting target analytes such as proteins or small molecules. The invention...
7252944 Methods and compositions for modulating cell proliferation  
This invention provides methods for identifying novel SHMT modulators. The methods comprise first screening test agents for modulators of p38 activity and then further screening the identified...
7252997 Structural protein of adeno-associated virus with modified antigenicity, its production and its use  
The invention relates to a structural protein of adeno-associated virus (AAV) that contains at least one modification that reduces the antigenicity of the virus. The invention further relates to...
7250251 Virion-based fusion assay  
The present invention features methods and compositions relating to a virion-based fusion assay for detection of infection of a target cell by an enveloped retroviral virion such as HIV. The assay...
7247457 Detection and identification of enteroviruses by semi-nested amplification of the enterovirus VP1 protein  
Disclosed are methods of using enterovirus-specific primers for the detection and identification of enterovirus infection. Also provided are isolated nucleic acid molecules and kits useful for...
7247425 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions  
The present invention provides methods for identifying evolutionarily significant polynucleotide and polypeptide sequences in human and/or non-human primates which may be associated with a...
7247439 Method of evaluating a patient antibody response to envelope proteins of a virus  
The invention provides a method for identifying whether a compound inhibits entry of a virus into a cell which comprises: (a) obtaining nucleic acid encoding a viral envelope protein from a patient...
7244578 Methods for modeling infectious disease and chemosensitivity in cultured cells and tissues  
The present invention provides methods for utilizing a form of optimized suspension culture to examine the infectivity of pathogenic organisms and agents in human cells and tissues. Also provided...
7244558 Production of novel Newcastle disease virus strains from cDNAs and improved live attenuated Newcastle disease vaccines  
The present invention concerns cDNAs for making attentuated, infectious Newcastle disease virus (NDV). Another aspect of the invention relates to methods of making the cDNAs. Another aspect of the...
7241630 Paramagnetic particle detection  
A method of determining the number of magnetic particles within a sample using a tuned circuit having a capacitor and a coil. The method comprises: a. determining the difference in the...
7241582 Diagnostic test kits  
This invention provides kits, devices, and methods for the detection of antibodies that recognize one or more proteins and/or antigens from porcine reproductive and respiratory syndrome virus...
7235356 Methods of evaluating cell surface receptor binding of a patient derived population of viral envelope protein constructs  
The invention provides a method for identifying whether a compound inhibits entry of a virus into a cell which comprises: (a) obtaining nucleic acid encoding a viral envelope protein from a patient...
7235387 Method for mutation detection in HIV-1 using pol sequencing  
The present invention relates to a method for mutation analysis of the HIV pol gene of HIV virions comprising amplifying virion RNA or DNA via nested PCR using outer primers as represented in SEQ...
7235393 Method for direct rescue and amplification of integrated viruses from cellular DNA of tissues  
A method for isolating AAV viruses from cellular DNA of non-human primate (NHP) tissues by transfecting the DNA of NHP into 293 cells, rescuing the virus and amplifying it through serial passages...
7232564 Methods of polyvalent bacteriophage preparation for the treatment of bacterial infections  
The multivalent strains of bacteriophages, methods of obtaining these and their use in the treatment of bacterial infections, particularly those of drug-resistant bacterial strains, especially...
7229777 Hairpin peptides with a novel structural motif and methods relating thereto  
The invention is directed to a model system for structure-activity relationship analysis of peptide or protein molecules involved in important biological processes. Provided by the invention are...
7229754 Sensing phage-triggered ion cascade (SEPTIC)  
The present invention provides a method for detecting bacteria and a nano-well device having one or more input/output connections about a gap and one or more bacteriophages at or about the gap that...
7226603 HBV core antigen particles with multiple immunogenic components attached via peptide ligands  
This invention relates to hepatitis B virus (“HBV”) core antigen particles that are characterized by multiple immunogen specificities. More particularly, the invention relates to HBV core...
7227632 Assembly for the optical illumination of a plurality of samples  
An assembly for an optical read out device for biochips, in which in a manner known per se an optical path of light that is emitted from the samples is evaluated by a CCD camera. For this purpose,...
7226774 Signal for packaging of influenza virus vectors  
The invention provides a packaging (incorporation) signal for influenza virus vectors, and methods of using the signal to transmit and maintain influenza viral and foreign nucleic acid in virus and...
7223535 Synthetic peptides immunoreactive with hepatitis A virus antibodies  
Synthetic peptides immunoreactive with hepatitis A virus (HAV) antibodies are provided. The peptides are useful as laboratory reagents to detect or quantify HAV antibodies in biological samples in...
7223534 Diffraction-based diagnostic devices  
A biosensor includes a substrate with a layer of receptive material disposed thereon. The receptive material is specific for an analyte of interest. A pattern of active and deactivated areas of the...
7220405 Peptide-based conditioners and colorants for hair, skin, and nails  
Peptides have been identified that bind with high affinity to hair, skin, and nails. Peptide-based hair conditioners, hair colorants, skin conditioners, skin colorants, and nail colorants are...
7220540 Methods for detecting bacteriophage MS2  
The present invention relates to methods and assays for detecting bacteriophage MS2 in a sample.
7217512 Reagent and method for attaching target molecules to a surface  
The present invention provides a method and reagent composition for attachment of target molecules onto the surface of a substrate, such as microwell plates, tubes, beads, microscope slides,...
7217506 Mutational profiles in HIV-1 protease correlated with phenotypic protease inhibitor resistance  
The present invention is directed to the field of nucleic acid diagnostics and the identification of base variation in target nucleic acid sequences. More particularly, the present invention...
7217507 Method for detecting ligands and targets in a mixture  
The invention provides a method of characterizing a target that binds to a ligand. The method comprises providing ligands, optionally attached to a support, and contacting the ligands with targets...
7211378 Filovirus vectors and noninfectious filovirus-based particles  
Cloned filovirus genomic cDNA and methods of using the cDNA are provided. Further provided are noninfectious lipid encapsulated filovirus-based particles.
7211379 Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2  
Provided is a method for reducing viral load of porcine circovirus type 2 (PCV-2) in a pig by inducing an immune response against PCV-2 through the administration of an immunogenic composition...
7211659 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof  
The present invention relates to polynucleotides encoding immunogenic HIV polypeptides. Uses of the polynucleotides in applications including immunization, generation of packaging cell lines, and...
7208293 Directed evolution of novel binding proteins  
In order to obtain a novel binding protein against a chosen target, DNA molecules, each encoding a protein comprising one of a family of similar potential binding domains and a structural signal...
7205280 Methods of suppressing microglial activation  
Methods of suppressing the activation of microglial cells in the Central Nervous System (CNS), methods of ameliorating or treating the neurological effects of cerebral ischemia or cerebral...
7205101 Human immunodeficiency virus (HIV) nucleotide sequences, recombinant polypeptides, and applications thereof  
Polynucleotide sequences are provided for the diagnosis of the presence of retroviral infection in a human host associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome,...
7204980 Methods for inhibiting viral replication in vivo  
The present invention is directed to methods of modulating viral replication in vivo comprising administering to an individual a therapeutically or prophylactically effective amount of a...
7205155 Method for the determination of substances using the evanescence field method  
This invention relates to a method for the determination of substances using the evanescence field method. A cuvette, a microtiter well, a solution and a kit for application in a method according...
7205100 Methods for reducing background fluorescence  
This invention relates to methods for reducing background fluorescence in cell detection and measurement systems. In accordance with one aspect of the invention, cell-impermeant chemical agents are...
7202021 Antibodies for specifically detecting pathogenic prions of human origin, and detection methods carried out using these antibodies  
This application includes description of antibodies for specifically detecting prions of human origin and methods for detecting pathogenic prions. In some embodiments, the antibodies bind to an...
7201902 Production of recombinant protein pap 31 for the diagnosis and prevention of Bartonella bacilliformis infection  
The invention relates to a recombinant DNA and polypeptide sequence of an immuno-dominant phage particle associated protein from Bartonella bacilliformis . The recombinant protein is easily...
7198934 Recombinant MVA virus, and the use thereof  
The present invention relates to recombinant vaccinia viruses derived from the modified vaccinia virus Ankara (MVA) and containing and capable of expressing foreign genes which are inserted at the...
7198923 Method for the preparation of purified HCV RNA by exosome separation  
The invention relates to a method for the isolation of hepatitis C virus. The method comprises the separation of particles termed exosomes from the blood plasma of an individual infected with...
7198891 Hepatitis C virus peptides and uses thereof  
Novel hepatitis C virus (HCV) polypeptides are provided which are not encoded by the standard HCV open reading frame. These alternate reading frame polypeptides are useful, inter alia, in vaccine...
7198793 Bovine immunodeficiency virus (BIV) based vectors  
This invention pertains to BIV constructs encompassing BIV combination vectors, BIV vectors and BIV packaging vectors and particularly the invention pertains to a three vector system comprising: a)...
7195874 Detecting targets in heterologous mixtures  
This invention relates to agents and conjugates that can be used to detect and isolate target components from complex mixtures such as nucleic acids from biological samples, cells from bodily...
7196183 Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent  
The present invention relates to genomic nucleotide sequences and amino acid sequences corresponding to the non-coding and coding region of a new type of HCV. The invention relates to new HCV types...